The global race to deliver proven antibody treatments and vaccines for COVID-19 is well underway. A slew of candidates — including many made possible by advances in synthetic biology — are in late-stage clinical trials.
The global race to deliver proven antibody treatments and vaccines for COVID-19 is well underway. A slew of candidates — including many made possible by advances in synthetic biology — are in late-stage clinical trials.